Healthequity (HQY) FCF Margin (2013 - 2026)

Healthequity has reported FCF Margin for 14 years, with the latest figure at 34.6% in Q3 2026.

• On a quarterly basis, FCF Margin fell 390.0% year-over-year to 34.6% in Q3 2026; TTM through Jul 2026 was 32.26%, a 746.0% increase from a year earlier, with the FY2026 full-year figure at 31.26%, up 719.0% from the prior year.
• FCF Margin was 34.6% for Q3 2026 at Healthequity, up from 23.01% in the prior quarter.
• The five-year high for FCF Margin was 39.82% in Q4 2025, with the low at 3.19% in Q2 2022.
• Average FCF Margin over 5 years is 22.39%, with a median of 20.05% recorded in 2025.
• The largest YoY upside for FCF Margin was 1408 bps in 2022 against a maximum downside of 1158 bps in 2022.
• Over 5 years, FCF Margin stood at 17.05% in 2022, then rose by 7 bps to 18.25% in 2023, then soared by 42 bps to 25.96% in 2024, then surged by 53 bps to 39.82% in 2025, then declined by 13 bps to 34.6% in 2026.
• The last three FCF Margin figures came in at 34.6% (Q3 2026), 23.01% (Q2 2026), and 32.33% (Q1 2026), per Business Quant data.